摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(5-((tert-butyldimethylsilyloxy)methyl)-4-hydroxy-tetrahydrofuran-2-yl)-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-2(3H)-one

中文名称
——
中文别名
——
英文名称
3-(5-((tert-butyldimethylsilyloxy)methyl)-4-hydroxy-tetrahydrofuran-2-yl)-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-2(3H)-one
英文别名
3-(5-((tert-butyldimethyl silyloxy)methyl)-4-hydroxy-tetrahydrofuran-2-yl)-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-2(3H)-one;3-[5-[[tert-butyl(dimethyl)silyl]oxymethyl]-4-hydroxyoxolan-2-yl]-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-2-one
3-(5-((tert-butyldimethylsilyloxy)methyl)-4-hydroxy-tetrahydrofuran-2-yl)-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-2(3H)-one化学式
CAS
——
化学式
C28H40N2O5Si
mdl
——
分子量
512.721
InChiKey
SVUIHVYHWYFHTI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.06
  • 重原子数:
    36
  • 可旋转键数:
    10
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.57
  • 拓扑面积:
    80.6
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Method of Preparation of Antiviral Compounds and Useful Intermediates Thereof
    申请人:Wang Yanling
    公开号:US20130331561A1
    公开(公告)日:2013-12-12
    The invention is directed to processes for synthesizing bicyclic nucleoside antiviral compounds and for synthesizing the intermediates used in the process. The invention is also directed to novel intermediate compounds useful in the process. The anti-viral compounds are useful in the treatment of herpes zoster (i.e., varicella zoster virus, VZV, shingles) and for the prevention of post herpetic neuralgia (PHN) resulting from this viral infection.
    该发明涉及合成双环核苷类抗病毒化合物的过程以及用于该过程的中间体的合成。该发明还涉及在该过程中有用的新型中间体化合物。这些抗病毒化合物可用于治疗带状疱疹(即水痘-带状疱疹病毒,VZV,带状疱疹)并预防由该病毒感染引起的后遗神经痛(PHN)。
  • Method of preparation of antiviral compounds and useful intermediates thereof
    申请人:Wang Yanling
    公开号:US09260469B2
    公开(公告)日:2016-02-16
    The invention is directed to processes for synthesizing bicyclic nucleoside antiviral compounds and for synthesizing the intermediates used in the process. The invention is also directed to novel intermediate compounds useful in the process. The antiviral compounds are useful in the treatment of herpes zoster (i.e., varicella zoster virus, VZV, shingles) and for the prevention of post herpetic neuralgia (PHN) resulting from this viral infection.
    本发明涉及合成双环核苷类抗病毒化合物的过程,以及用于该过程的中间体的合成。本发明还涉及在该过程中有用的新型中间体化合物。这些抗病毒化合物可用于治疗带状疱疹(即水痘带状疱疹病毒,VZV,带状疱疹)并预防由该病毒感染引起的后遗神经痛(PHN)。
  • METHOD OF PREPARATION OF ANTIVIRAL COMPOUNDS AND USEFUL INTERMEDIATES THEREOF
    申请人:ContraVir Pharmaceuticals, Inc.
    公开号:US20160122381A1
    公开(公告)日:2016-05-05
    The invention is directed to processes for synthesizing bicyclic nucleoside antiviral compounds and for synthesizing the intermediates used in the process. The invention is also directed to novel intermediate compounds useful in the process. The antiviral compounds are useful in the treatment of herpes zoster (i.e., varicella zoster virus, VZV, shingles) and for the prevention of post herpetic neuralgia (PHN) resulting from this viral infection.
    本发明涉及合成双环核苷类抗病毒化合物的方法,以及用于该过程的中间体的合成方法。本发明还涉及在该过程中有用的新型中间体化合物。这些抗病毒化合物可用于治疗带状疱疹(即水痘带状疱疹病毒,VZV,带状疱疹)并预防由该病毒感染导致的带状疱疹后神经痛(PHN)。
  • [EN] METHOD OF PREPARATION OF ANTIVIRAL COMPOUNDS AND USEFUL INTERMEDIATES THEREOF<br/>[FR] PROCÉDÉ DE PRÉPARATION DE COMPOSÉS ANTIVIRAUX ET INTERMÉDIAIRES UTILES DE CEUX-CI
    申请人:INHIBITEX INC
    公开号:WO2012048202A3
    公开(公告)日:2012-07-26
查看更多

同类化合物

呋喃并[2,3-d]嘧啶-4(1H)-酮 呋喃并[2,3-d]嘧啶-2(3H)-酮 呋喃并[2,3-d]嘧啶 6-苯基呋喃并[2,3-D]嘧啶-4-胺 6-甲基呋喃并[2,3-d]嘧啶-4-胺 6-甲基呋喃并[2,3-d]嘧啶-4(3H)-酮 6-(4-甲氧基苯基)呋喃并[2,3-d]嘧啶-4-胺 6-(4-甲氧基苯基)-5-(3-吡啶)-呋喃并[2,3-d]嘧啶-4-胺 6-(4-甲基苯基)-呋喃并[2,3-d]嘧啶-4-胺 6-(4-溴-苯基)-4-氯-呋喃并[2,3-d]嘧啶 6-(4-氯苯基)-呋喃并[2,3-d]嘧啶-4-胺 6-(3-溴-苯基)-4-氯-呋喃并[2,3-d]嘧啶 6-(3-吡啶)-呋喃并[2,3-d]嘧啶-4-胺 5-甲基呋喃并[2,3-d]嘧啶-4-胺 5-溴呋喃并[2,3-D]嘧啶-4-胺 5-氯甲基呋喃并[2,3-d]嘧啶-2,4-二胺 5,6-二甲基呋喃[2,3-d]嘧啶-4-胺 4-氯呋喃[2,3-D]嘧啶 4-氯-6-甲基-呋喃并[2,3-d]嘧啶 4-氨基呋喃并[2,3-D]嘧啶 4,6-二甲基呋喃并[2,3-d]嘧啶 4,6-二甲基呋喃并[2,3-D]嘧啶-2-胺 3-(2-脱氧-beta-D-赤式-呋喃戊糖基)-6-甲基呋喃并[2,3-d]嘧啶-2(3H)-酮 2-甲基硫代呋喃并[2,3-d]嘧啶-6-甲醇 2,4-二氯呋喃并[2,3-d]嘧啶 2,4-二氯-5-甲基呋喃并[2,3-d]嘧啶 5,6-dimethylfuro<2,3-d>pyrimidine-4-carbonitrile 6-(3-aminophenyl)-N-[(1R)-1-phenylethyl]furo[2,3-d]pyrimidin-4-amine 6-(3-aminophenyl)-N-(3-chlorophenyl)furo[2,3-d]pyrimidin-4-amine 2-{[6-(3-aminophenyl)furo[2,3-d]pyrimidin-4-yl]amino}-4-chlorophenol 6-(3-aminophenyl)-N-(4-chloro-2-fluorophenyl)-furo[2,3-d]pyrimidin-4-amine 6-(3-aminophenyl)-N-(3,5-dichlorophenyl)furo[2,3-d]pyrimidin-4-amine 5-{[6-(3-aminophenyl)furo[2,3-d]pyrimidin-4-yl]amino}-2-methylphenol 1-(6-[4-(2-dimethylamino-ethoxy)-phenyl]-5-methyl-2-thiophene-2-yl-furo[2,3-d]pyrimidin-4-ylamino)-3-methyl-pyrrole-2,5-dione (R)-4-(4-((1-phenylethyl)amino)furo[2,3-d]pyrimidin-6-yl)benzonitrile pyrrolidine-1-carboxylic [6-(4-methoxy-phenyl)-furo[2,3-d]pyrimidin-4-yl]-amide N3-[(1-benzyl-1,2,3-triazol-4-yl)methyl]-6-(hex-1-yl)furo[2,3-d]pyrimidine-2-one N3-{[1-(4-chlorophenyl)-1,2,3-triazol-4-yl]methyl}-6-(hex-1-yl)-5-(oct-1-yn-1-yl)furo[2,3-d]pyrimidine-2-one N3-{[1-(2-fluorophenyl)-1,2,3-triazol-4-yl]methyl}-(6-hex-1-yl)furo[2,3-d]pyrimidine-2-one 6-pentyl-2,3-dihydrofuro[2,3-d]pyrimidin-2-one 2-[(5,6-di-(2-furyl)-furo[2,3-d]pyrimidin-4-yl)aminoethoxy]ethanol 6-(4-n-pentylphenyl)-2,3-dihydrofuro[2,3-d]pyrimidin-2-one 2-[(5,6-di-(2-furyl)-furo[2,3-d]pyrimidin-4-yl)amino]butan-1-ol 4-[(5,6-di-(2-furyl)-furo[2,3-d]pyrimidin-4-yl)amino]butan-1-ol 4-chloro-5,6-dimethylfuro[2,3-d]pyrimidine 3-butyl-6-(hexylsulfanylmethyl)furo[2,3-d]pyrimidin-2(3H)-one 3-dodecyl-6-(hexylsulfanylmethyl)furo[2,3-d]pyrimidin-2(3H)-one 6-(hexylsulfanylmethyl)-3-octylfuro[2,3-d]pyrimidin-2(3H)-one 3-decyl-6-(hexylsulfanylmethyl)furo[2,3-d]pyrimidin-2(3H)-one 6-decyl-2-propoxyfuro[2,3-d]pyrimidine